|
Stephen Sullivan PhD MBA MSc
Chief Operating Officer
iPSirius
|
Dr. Stephen Sullivan is a respected leader and scientist in the field of cell and gene therapy. He is currently the Chief Operating Officer and a Member of the Board of Directors at iPSirius, an immunotherapy company in Paris, France. With patented technology for creating human cancer vaccines from induced pluripotent stem (iPS) cells, iPSirius aims to revolutionize cancer treatment. Dr. Sullivan has extensive experience in stem cell research and regenerative medicine and has made significant contributions to the development of innovative therapies. He is also the Founder and Managing Director of Lindville Bio, a consultancy focused on pluripotent stem cell manufacturing and ATMP development. Additionally, Dr. Sullivan has held various committee positions in organizations such as the International Stem Cell Banking Initiative, The International Society for Cell and Gene Therapy and the Global Alliance for iPSC Therapies. He obtained his Ph.D. in Stem Cell Biology from the University of Edinburgh and conducted research at prestigious institutions like University of Cambridge, Harvard University, and University of California San Diego. Dr. Sullivan's expertise and leadership have positioned him as a highly regarded figure in the scientific community, driving advancements in cell and gene therapies.